Pharmacological treatment of acute heart failure: current treatment and new targets

Clin Pharmacol Ther. 2013 Oct;94(4):499-508. doi: 10.1038/clpt.2013.136. Epub 2013 Nov 17.

Abstract

Acute heart failure (AHF) is defined as the rapid onset of, or changes in, the symptoms and signs of heart failure (HF). It is a life-threatening situation in which diagnosis and initiation of therapy are crucial. The treatment aims are to stabilize the patient, improve clinical symptoms, and increase long-term survival rates. Few treatments have been investigated in clinical trials. This review summarizes the principles of pharmacologic treatment, the underlying clinical trials, and new pharmacologic targets.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Analgesics, Opioid / therapeutic use
  • Cardiotonic Agents / therapeutic use
  • Diuretics / therapeutic use
  • Drugs, Investigational / therapeutic use*
  • Heart Failure / drug therapy*
  • Humans
  • Molecular Targeted Therapy / trends*
  • Opioid Peptides
  • Oxygen / therapeutic use
  • Practice Guidelines as Topic
  • Vasoconstrictor Agents / therapeutic use
  • Vasodilator Agents / therapeutic use

Substances

  • Analgesics, Opioid
  • Cardiotonic Agents
  • Diuretics
  • Drugs, Investigational
  • Opioid Peptides
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Oxygen